Novo Nordisk partners with Anthropic to accelerate drug discovery
Novo Nordisk has entered an AI partnership with Anthropic aimed at accelerating drug development, which could potentially reduce timelines and costs while increasing industry competition.
Summaries are written by AI from the original article. Not investment advice.